Skip to content
    Revelation Partners logo

    Revelation Partners

    Sausalito, California, United StatesFounded 2015
    revelation-partners.comLinkedIn
    HealthcareBiotech & Life Sciences

    Revelation Partners is a healthcare-focused secondaries investment firm providing flexible capital and liquidity solutions—including direct secondaries, continuation vehicles, and growth equity—to the healthcare ecosystem. Headquartered in Sausalito, California, the firm manages over $2.2 billion of committed capital across all healthcare sub-sectors.

    48% of their portfolio is in Healthcare. Deal activity decreased year-over-year (1 deal in the last 12 months vs 2 prior). Average disclosed round size is $68.5M (across 25 rounds with reported amounts).

    Find people at Revelation Partners on Goldilocks AI

    Portfolio

    19

    Fund Size

    $608M

    Top Stage

    Series C

    Last 12 Mo

    1

    Team

    MB

    Mike Boggs

    Managing Partner

    SH

    Scott Halsted

    Managing Partner

    DF

    Doug Fisher, MD

    Partner

    FL

    Fred Lee

    Partner

    JA

    Jonathan Au

    Partner

    RR

    Rob Rein

    Principal

    KH

    Keegan Hasson

    Vice President

    VV

    Victoria Valverde

    Healthcare Investor

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    27 investments
    CompanyRoundAmountDate
    Aspen Neuroscience logoAspen NeuroscienceSeries C$115MNov 2025
    Arbor Biotechnologies logoArbor BiotechnologiesSeries C$73.9MMar 2025
    VitalConnect logoVitalConnectSeries G$100MFeb 2025
    VitalConnect logoVitalConnectSeries F$30MJan 2025
    Vedanta Biosciences logoVedanta BiosciencesSeries D$40MJan 2024
    Nouscom logoNouscomSeries C—Nov 2023
    Carrum Health logoCarrum HealthSeries B$45MMay 2023
    Aspen Neuroscience logoAspen NeuroscienceSeries B$147.5MMay 2022
    Aspen Neuroscience logoAspen NeuroscienceSeries B—May 2022
    IntelyCare, Inc. logoIntelyCare, Inc.Series C$115MApr 2022
    Gravie logoGravieSeries E$75MMar 2022
    Endeavor Biomedicines logoEndeavor BiomedicinesSeries B$101MFeb 2022
    HotSpot Therapeutics logoHotSpot TherapeuticsSeries C$100MNov 2021
    SetPoint Medical logoSetPoint MedicalSeries D$64MJan 2021
    Click Therapeutics logoClick TherapeuticsSeries B$48.5MJan 2021
    SomaLogic logoSomaLogicSeries A$214MDec 2020
    EEvidation Health, Inc.Series D$45MJul 2020
    NeuroPace logoNeuroPaceUnknown$67MJan 2020
    SomaLogic logoSomaLogicSeries A$121MJan 2020
    Vedanta Biosciences logoVedanta BiosciencesSeries C$16.6MSep 2019
    Providence Medical Technology logoProvidence Medical TechnologyUnknown$25MSep 2018
    EEvidation Health, Inc.Series D$45MAug 2018
    Arterys logoArterysSeries A$12MJan 2016
    SSpr TherapeuticsUnknown$25M—
    Arterys logoArterysSeries C$28M—
    Page 1 of 2

    Top Co-Investors

    Ally Bridge Group4 shared
    OrbiMed4 shared
    B Capital3 shared
    Temasek Holdings (Private) Limited3 shared
    T. Rowe Price3 shared
    ARCH Venture Partners3 shared
    Lifeforce Capital3 shared
    S323 shared
    LYFE Capital3 shared
    Soleus Capital3 shared
    Stanford's StartX Fund3 shared
    Scale Venture Partners2 shared
    EQT Life Sciences2 shared
    Piper Heartland Healthcare Capital2 shared
    Mirae Asset2 shared
    EDBI2 shared
    GV2 shared
    Timefolio Capital2 shared
    Frazier Life Sciences2 shared
    AVP2 shared

    Last updated: 20 October 2026